US Edition51 GOP Senators Urge Kennedy, FDA to Take Mifepristone Off the Market
- Fifty-One Republican senators urged Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary to take mifepristone off the market, citing safety concerns and recent lawsuits over abortion pills.
- The senators criticized the Biden administration's policies allowing mail-order access to mifepristone, stating that this has led to increased risks for women and violations of state laws.
- They requested the FDA to halt approvals for new generic versions of mifepristone while a comprehensive safety review is underway, emphasizing the urgency of the situation.
- The letter pointed out that 51 U.S. Senators recognized the dangers associated with mifepristone, calling it a health emergency needing immediate attention.
23 Articles
23 Articles
997wpro.com
51 GOP Senators Urge Kennedy, FDA to Take Mifepristone Off the Market
Fifty-one Republican senators are pressing Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Marty Makary to take mifepristone, one of the drugs used in medication abortions, off the market. "Your agencies have all the information they need to bring an end to previous Democrat administrations' abortion drug regulations while a comprehensive review is conducted," they wrote in a letter Thursda…
51 GOP Senators Urge Kennedy, FDA to Take Mifepristone off the Market
More than 50 Republican senators are pressing Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Marty Makary to take mifepristone, one of the drugs used in medication abortions, off the market.
Conservative Review
The Constitution Study51 GOP Senators Urge HHS, FDA To End Distribution Of Dangerous Abortion Drug
The Republicans also noted that mail-order abortion pills are 'systematically undermining states’ rights and violating pro-life state laws.'
Coverage Details
Bias Distribution
- 62% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
